Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN
19 hours ago • Google News
TG Therapeutics Inc (TGTX)
US$ 33.64-0.65%
Price Chart
Key Statistics
Market Cap
$ 5.83B
P/E Ratio
146.88
Revenue (TTM)
$ 386.39M
Volume
2.21M
52W High
$ 46.48
52W Low
$ 16.65
Dividend Yield
0.00%
Beta
1.94
Technicals
50-Day MA
37.0424
200-Day MA
32.689
52 Week High
46.48
52 Week Low
16.65
About TGTX
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United State.
Employees
352
Headquarters
Morrisville, NC
CEO
Mr. Michael S. Weiss Esq.
Latest News
TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) - Seeking Alpha
2025-05-28 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg